Editorial: CD4+ T Cells in Cancer Immunotherapies

José M. González-Navajas; Eyad Elkord; Jongdae Lee

doi:10.3389/fimmu.2021.737615

Editorial: CD4⁺ T Cells in Cancer Immunotherapies

José M. González-Navajas^*, Eyad Elkord, Jongdae Lee

^*Corresponding author for this work

School of Science

Research output: Contribution to journal › Editorial

3 Citations (Scopus)

Original language	English
Article number	737615
Journal	Frontiers in Immunology
Volume	12
DOIs	https://doi.org/10.3389/fimmu.2021.737615
Publication status	Published - 6 Sept 2021

Keywords

cancer
CD4
immune checkpoint inhibitor (ICI)
immunotherapy
T lymphocyte

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fimmu.2021.737615

Cite this

@article{eac44dc2f2964eceaec61be995aec825,

title = "Editorial: CD4+ T Cells in Cancer Immunotherapies",

keywords = "cancer, CD4, immune checkpoint inhibitor (ICI), immunotherapy, T lymphocyte",

author = "Gonz{\'a}lez-Navajas, {Jos{\'e} M.} and Eyad Elkord and Jongdae Lee",

year = "2021",

month = sep,

day = "6",

doi = "10.3389/fimmu.2021.737615",

language = "English",

volume = "12",

journal = "Frontiers in Immunology",

issn = "1664-3224",

}

TY - JOUR

T1 - Editorial

T2 - CD4+ T Cells in Cancer Immunotherapies

AU - González-Navajas, José M.

AU - Elkord, Eyad

AU - Lee, Jongdae

PY - 2021/9/6

Y1 - 2021/9/6

KW - cancer

KW - CD4

KW - immune checkpoint inhibitor (ICI)

KW - immunotherapy

KW - T lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=85115406150&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2021.737615

DO - 10.3389/fimmu.2021.737615

M3 - Editorial

C2 - 34552596

AN - SCOPUS:85115406150

SN - 1664-3224

VL - 12

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 737615

ER -